Article Sidebar
Views PDF: 142
Research effects of 100 mCi dose Iodine- 131 on bone marrowin therapy for operated differentiated thyroid carcinoma
Main Article Content
Abstract
SUMMARY
Researching into the effects of 100 mCi dose I-131 on bone marrow of 31 operated differentiated thyroid carcinoma patients, after 03 months of I-131 therapy, through the characteristics of peripheral blood cells and hematopoietic precursors of bone marrow, comparing with prior to I-131 therapy, the results showed that:
On the peripheral blood circulation: Lymphocyte and thrombocyte counts were decreased obviously (p< 0.05). However, the mean values of lymphocyte and thrombocyte counts still belong to normal reference values; Erythrocyte lineage has not yet had affected signs of I-131 at dose of 100 mCi, that causes the decresae in erythrocyte count and hemoglobin concentration; The increase of patient percentage with unusual cytoplasm of Neutrophils (hypogranular neutrophil or the presence of vacuoles in cytoplasm)
(p= 0.01); The increase of patient percentage with large thrombocyte in dimension (p= 0.038).
On bone marrow: bone marrow cell counts were decreased
(p= 0.0001). However, the mean value of bone marrow cell counts still belong to normal reference value; The decrease of patient percentage found lymphocytic precursors and Basophilic meakaryocytes (p < 0.001); The increase of patient percentage found lymphocytes with cleaved nucleus (p= 0.01); The increase of patient percentage with unusual cytoplasm of granulocytic precursors (decreased azurophilic granules or the presence of vacuoles in cytoplasms) (p < 0.05).
Article Details
Keywords
Eeffects of 100 mCi dose Iodine- 131 on bone marrow
References
1. Bộ môn Y học Hạt nhân, Trường Đại học Y Hà Nội, Y học Hạt nhân. Nhà xuất bản Đại học Y Hà Nội, (2005), tr. 134 – 137.
2. Trịnh Thị Minh Châu: Kinh nghiệm 10 năm điều trị ung thư tuyến giáp bằng đồng vị phóng xạ 131I tại Bệnh viện Chợ Rẫy. Y học thành phố Hồ Chí Minh, Chuyên đề ung bướu học, phụ bản, tập 8, số 4 (2004), tr. 154 – 162.
3. Vũ Trung Chính, Nguyễn Hữu Thợi, Phạm Thị Minh Bảo. Áp dụng phương pháp điều trị ung thư giáp trạng thể biệt hóa bằng I- 131 phối hợp sau phẫu thuật cắt thùy tuyến giáp toàn bộ. Hội thảo quốc gia về phòng chống ung thư. Tạp chí Y học thực hành, NXB Bộ Y tế, số 489, (2004), tr. 51 – 255.
4. Nguyễn Văn Kính. Nghiên cứu biến đổi di truyền tế bào ở bệnh nhân ung thư tuyến giáp thể biệt hóa được điều trị bằng I- 131. Luận án tiến sĩ Y học (2008).
5. Đỗ Trung Phấn. Bệnh lý tế bào nguồn tạo máu. NXB Y học (2003), tr. 11 – 18.
6. Alexander C., Bader J. B., Schaefer A., Finke C., Kirsch C. M., Intermediate and long- term side effects of high- dose radioiodine therapy for thyroid carcinoma, J Nucl Med (1998) 39, pp. 1551 – 1554.
7. Douglas Van Nostrand, Janet Neutze, and Francis Atkins. Nuclear Medicine Service, Uniformed Services University of Health Sciences, Walter Reed Army Medical, Washington, DC. Side Effects of “ Rational Dose” Iodine- 131 Therapy for Metastatic Well- Differentiated Thyroid Carcinoma. Journal of Nuclear Medicine, (1986), Volume 27: 1519 – 1527.
8. Fred A. Mettler, Jr. M. D. Arthur C. Upton, M. D., Radiation effects on hematopoietic and lymphatic systems. Medical effects of ionizing radiation, W. B Saunders Company, USA, (1995), pp. 17 -22, 52 – 66, 104 – 105, 265 – 275.
9. Menzel C., Grunwald F., Schomburg A., et al. High- dose radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med (1996) 37, pp. 1496 – 1503.
10. SM Chow. Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong. Side Effects of High- dose Radioactive Iodine for Ablation or Treatment of Differentiated Thyroid Carcinoma. Journal of HK Coll Radiol, (2005),Volume 8, pp. 127 – 135.